Lopez-Vicario et al. demonstrated that sEH inhibition rescued autophagy dysregulation in a HFD mouse model of NAFLD using the sEHI t-TUCB [42]. This evidence concerns the gene EPHX2 and metabolic dysfunction-associated steatotic liver disease.